Market Overview

UPDATE: Citigroup Initiates Maximus at Buy on Health Care Reform Opportunities

Share:
Related MMS
Earnings Scheduled For February 9, 2017
Benzinga's Top Upgrades, Downgrades For January 17, 2017

Citigroup initiated coverage on Maximus (NYSE: MMS) with a Buy rating and a $75 price target.

Citigroup said, "Over the next three years, we think Maximus can more than double earnings. The company will continue to benefit from states moving fee for service Medicaid programs over to managed care. Moreover, Health Reform creates incremental growth opportunities from the Medicaid expansion and health exchanges. We think earnings can grow to $4.20 per share in 2015, and estimate the benefit of health exchanges and capital deployment could add another $0.70 per share."

Maximus closed at $63.09 on Monday.

Latest Ratings for MMS

DateFirmActionFromTo
Jan 2017Avondale PartnersDowngradesMarket OutperformMarket Perform
Nov 2016Sidoti & Co.DowngradesBuyNeutral
Nov 2016Raymond JamesDowngradesOutperformMarket Perform

View More Analyst Ratings for MMS
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (MMS)

View Comments and Join the Discussion!